Psilocybin is the major psychoactive compound present in magic mushrooms. Much like cannabis, psilocybin is classified as a Schedule 1 controlled substance with no medical purpose. However, recent studies have identified important medical effects of psilocybin. One area where psilocybin has been purported to affect is in the treatment of depression. The beneficial compound has been approved on two occasions for trials regarding depression by the FDA. The first trial for the compound was for severe treatment-resistant depression. The second approval was directed towards major depressive disorder. Major depressive disorder is a very common condition with over 300 million suffering from the condition.
Try Cornbread Hemp's new USDA-certified organic THC gummy. It's the first hemp THC gummy of…
Register to vote today to make your voice heard. The post Cannabis voter guide to…
We've all heard it before: smoke weed, and you'll become a lazy, unmotivated bum. The…
New THC+CBC Mood Mints from Rare Cannabinoid Company bring on mood-boosting effects quickly thanks to…
Pioneering research from Columbia University in New York suggests that psilocybin, the key component in…
A groundbreaking new study, funded by the Centers for Disease Control and Prevention, suggests exactly…